R

Regencell Bioscience Holdings Limited

D
RGC
USD
-0.69
(-9.067%)
Market Closed
1,693.00
Volume
EPS
-
Div Yield
-19.222222
P/E
90,049,032.72
Market Cap
Today
-9.0670%
1 Week
-2.260%
1 Month
50.435%
6 Months
29.588%
12 Months
-53.148%
Year To Date
-28.880%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
AEM
AEM
1.27
(1.5272%)
USD
F
FNV
-1.7
(-1.2698%)
USD
GOLD
GOLD
-0.445
(-2.3582%)
USD
N
NEM
0.23
(0.517%)
USD
P
PAAS
0.295
(1.3137%)
USD
A
AU
2.42
(9.5126%)
USD
A
AGI
-0.73
(-3.6192%)
USD
S
SSRM
-0.46
(-7.5041%)
USD
E
EGO
-0.22
(-1.3398%)
USD

Title:
Regencell Bioscience Holdings Limited

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
Do you need help or have a question?
Contact Us